As part of broad drug pricing deals with the Trump administration, more than two dozen pharma companies agreed to sell drugs to state Medicaid programs at prices available in peer countries under ...
Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...
We’re very actively hiring,” Karim Mikhail, director of FDA’s Center for Biologics Evaluation and Research, told drug ...
Several Texas hospitals are suing an out-of-state Blue Cross for unpaid medical claims, highlighting the varying standards for whether care is medically necessary.
Health secretary Kennedy announced a new effort to improve autism diagnoses, arguing that the current model is outdated ...
Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force, an influential panel of experts who assess ...
A gene therapy approved for Sanfilippo syndrome, good and bad news for Xenon Pharma, and more biotech news ...
The FDA approved a new gene therapy for Sanfilippo syndrome type A, an ultra-rare disease sometimes known as childhood ...
Kennedy speaks at the Children's Health Defense, medical facilities under attack in Sudan, and more health news form Morning Rounds ...
A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of ...
Over the past 25 years, there’s been a dramatic change in how we understand children who don’t “listen,” writes behavioral ...
FDA's hiring bottleneck, Dems plan for health care oversight, and more from STAT's D.C. Diagnosis newsletter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results